Pharmacogenetics and stomach cancer: an update

Related Experiment Video

Updated: Jul 15, 2026

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform
06:21

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform

Published on: May 10, 2024

Giuseppe Toffoli1, Erika Cecchin

  • 1C.R.O.-National Cancer Institute, Experimental and Clinical Pharmacology, via Franco Gallini 2, 33081 Aviano (PN), Italy. gtoffoli@cro.it

Pharmacogenomics
|May 1, 2007
PubMed

Insights

Pharmacogenetics can optimize gastric cancer chemotherapy by identifying patients who benefit most from drugs like 5-fluorouracil. Genetic markers in thymidylate synthase and glutathione S-transferase show promise for personalized treatment strategies.

Area of Science:

  • Oncology
  • Pharmacogenetics
  • Cancer Genomics

Background:

  • Gastric cancer chemotherapy outcomes remain poor despite advances.
  • Personalized medicine approaches are needed to improve patient survival and reduce severe side effects.
  • Pharmacogenetics offers a strategy to tailor chemotherapy based on individual genetic profiles.

Purpose of the Study:

  • To review the role of pharmacogenetics in optimizing gastric cancer chemotherapy.
  • To highlight key genetic polymorphisms influencing response to common chemotherapeutic agents.
  • To discuss future directions, including targeted therapies and pharmacogenetic applications.

Main Methods:

  • Literature review of recent studies on gastric cancer pharmacogenetics.
  • Analysis of genetic polymorphisms in thymidylate synthase and glutathione S-transferase.
  • Evaluation of their impact on treatment with 5-fluorouracil and platinum derivatives.

Main Results:

  • Genetic polymorphisms in thymidylate synthase and glutathione S-transferase are significant in gastric cancer pharmacogenetics.
  • These polymorphisms affect patient response to 5-fluorouracil and platinum-based chemotherapy.
  • Further large-scale, controlled studies are necessary to validate these genetic markers.

Conclusions:

  • Pharmacogenetics is crucial for optimizing gastric cancer treatment, identifying suitable candidates for chemotherapy.
  • Genetic markers like polymorphisms in thymidylate synthase and glutathione S-transferase are key for personalized drug selection.
  • Future research should focus on validating these markers and exploring pharmacogenetics in targeted gastric cancer therapies.

More Related Videos

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

Related Concept Videos

Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
Pharmacogenetics of Drug Metabolism: Overview01:27

Pharmacogenetics of Drug Metabolism: Overview

Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...